Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Suspended 1Recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Dermatologic 6Genitourinary 4Gastrointestinal 3Thoracic 1Other neoplasm 1Head & Neck 1CNS 1

Conditions

Pancreatic Neoplasms 2Pancreatic Intraductal Neoplasms 1Barrett Esophagus 1

Interventions

Oxaliplatin 1413Fluorouracil 1301Capecitabine 1087Gemcitabine 1045Leucovorin 932Irinotecan 818Bevacizumab 804Cisplatin 669Radiotherapy 536Cetuximab 470pembrolizumab 428Paclitaxel 390Nivolumab 337130-nm albumin-bound paclitaxel 325Drug Therapy 314Docetaxel 287S 1 (combination) 274Sorafenib 266Folfox protocol 261Albumin-Bound Paclitaxel 259sintilimab 211durvalumab 210Surgical Procedures, Operative 204tislelizumab 203Radiosurgery 202lenvatinib 201apatinib 200Carboplatin 187Magnetic Resonance Spectroscopy 183regorafenib 181

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Tomography, Optical Coherence × Gastrointestinal × Clear all
NCT06906562 2026-02-17

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

Ohio State University Comprehensive Cancer Center

Phase 2 Recruiting
40 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT03711890 2025-03-30

Ultra-High Resolution Optical Coherence Tomography in Detecting Micrometer Sized Early Stage Pancreatic Cancer in Participants With Pancreatic Cancer

Ohio State University Comprehensive Cancer Center

Phase NA Suspended
75 enrolled
Gastrointestinal

Pancreatic Intraductal Neoplasms, Pancreatic Neoplasms

NCT03434834 2021-04-06

OCT Pilot in Esophagus

Duke University

Phase NA Completed
53 enrolled 9 charts
Gastrointestinal

Barrett Esophagus

Data powered by HemOnc (CC BY 4.0) Colophon âš¡